Literature DB >> 1431246

Clinical and laboratory comparison of botulism from toxin types A, B, and E in the United States, 1975-1988.

B A Woodruff1, P M Griffin, L M McCroskey, J F Smart, R B Wainwright, R G Bryant, L C Hutwagner, C L Hatheway.   

Abstract

Cases of adult botulism (n = 309) were studied to identify clinical differences between toxin types and to evaluate the sensitivity of diagnostic laboratory testing. Patients with illness from type E toxin had the shortest incubation periods. Sporadic case-patients were more severely ill: 85% required intubation compared with only 42% in multiperson outbreaks. Of patients with type A botulism, 67% required intubation compared with 52% with type B and 39% with type E. Toxin testing was positive for 40%-44% of serum and stool specimens obtained within 3 days of toxin ingestion and for 15%-23% of specimens obtained thereafter, while 37% of stool specimens obtained > 3 days after toxin ingestion were positive by culture. Patients with type A botulism have more severe illness. In general, specimens obtained early are more likely to be positive by toxin assay, and stool cultures are more sensitive than toxin detection for specimens obtained later in the illness.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1431246     DOI: 10.1093/infdis/166.6.1281

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  39 in total

1.  Positive ice pack test in a case of food-borne botulism: a clinical note.

Authors:  G Cosentino; E Alfonsi; D Lonati; C A Locatelli; F Valentino; F Brighina
Journal:  J Neurol       Date:  2012-06-30       Impact factor: 4.849

2.  Llama-derived single-domain antibodies for the detection of botulinum A neurotoxin.

Authors:  Marla D Swain; George P Anderson; Dan Zabetakis; Rachael D Bernstein; Jinny L Liu; Laura J Sherwood; Andrew Hayhurst; Ellen R Goldman
Journal:  Anal Bioanal Chem       Date:  2010-06-28       Impact factor: 4.142

3.  Wound botulism from heroin skin popping.

Authors:  Larry E Davis; Molly K King
Journal:  Curr Neurol Neurosci Rep       Date:  2008-11       Impact factor: 5.081

4.  Case 2: An infant with hypotonia and constipation.

Authors:  Abdulla Aljunaibi; Michael Weinstein
Journal:  Paediatr Child Health       Date:  2004-09       Impact factor: 2.253

5.  A Novel Rabbit Spirometry Model of Type E Botulism and Its Use for the Evaluation of Postsymptom Antitoxin Efficacy.

Authors:  Eran Diamant; Avi Pass; Osnat Rosen; Alon Ben David; Amram Torgeman; Ada Barnea; Arnon Tal; Amir Rosner; Ran Zichel
Journal:  Antimicrob Agents Chemother       Date:  2018-03-27       Impact factor: 5.191

6.  Diversity of proteolytic Clostridium botulinum strains, determined by a pulsed-field gel electrophoresis approach.

Authors:  Mari Nevas; Miia Lindström; Sebastian Hielm; K Johanna Björkroth; Michael W Peck; Hannu Korkeala
Journal:  Appl Environ Microbiol       Date:  2005-03       Impact factor: 4.792

7.  Black Tar Heroin Skin Popping as a Cause of Wound Botulism.

Authors:  Ihtesham A Qureshi; Mohtashim A Qureshi; Mohammad Rauf Afzal; Alberto Maud; Gustavo J Rodriguez; Salvador Cruz-Flores; Darine Kassar
Journal:  Neurocrit Care       Date:  2017-12       Impact factor: 3.210

8.  Phylogenetic analysis of Clostridium botulinum type A by multi-locus sequence typing.

Authors:  Mark J Jacobson; Guangyun Lin; Thomas S Whittam; Eric A Johnson
Journal:  Microbiology       Date:  2008-08       Impact factor: 2.777

9.  Newly Designed Quinolinol Inhibitors Mitigate the Effects of Botulinum Neurotoxin A in Enzymatic, Cell-Based, and ex Vivo Assays.

Authors:  Paul T Bremer; Michael Adler; Cecilia H Phung; Ajay K Singh; Kim D Janda
Journal:  J Med Chem       Date:  2017-01-03       Impact factor: 7.446

10.  Quantum dot immunoassays in renewable surface column and 96-well plate formats for the fluorescence detection of botulinum neurotoxin using high-affinity antibodies.

Authors:  Marvin G Warner; Jay W Grate; Abby Tyler; Richard M Ozanich; Keith D Miller; Jianlong Lou; James D Marks; Cynthia J Bruckner-Lea
Journal:  Biosens Bioelectron       Date:  2009-06-26       Impact factor: 10.618

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.